21 views 0 likes

StayCurrentMD

GCMD Space · View profile →

Update Course Rewind: Botox in Hirschsprung Disease 2023

Video Published 2024-02-01 Updated 2026-08-01

Timestops (16)

0:00
Global Cat MD along with Cincinnati Children's Hospital
Global Cat MD along with Cincinnati Children's Hospital, sharing knowledge to improve child health around the globe. Hel…
0:26
In this video series
In this video series, we'll recap the sessions and share the main highlights with you. Today our topic is Botox and Hirs…
0:45
5 month old male with diagnosis of Hirschprung disease statu…
5 month old male with diagnosis of Hirschprung disease status post Swenson pull through an infancy at your institution. …
1:07
What is your next step?
What is your next step? You have to always do your due diligence with a patient who has had their pull through. Why are …
1:27
And here Dr.
And here Dr. Smith is opening a discussion for using Botox in these patients. How do you do your Botox? In reading every…
1:48
I'm usually more like 34 in the dentate line.
I'm usually more like 34 in the dentate line. What about you? Yeah, I do 100 units, same 1 cc of saline. What's been. Co…
1:59
What do you think causes it?
What do you think causes it? I know, you know, no matter what operation we do for Hirschprung's, we always leave a gangl…
2:17
What are your thoughts?
What are your thoughts? In order to maintain continence, you want to preserve the dentate line, and you have to leave a …
2:41
There's poor emptying and motility issues
There's poor emptying and motility issues, and if you're not very diligent and about clearing the colon, it just has the…
3:06
Something that's very interesting is we know that there's a …
Something that's very interesting is we know that there's a significantly higher rate of enterocolitis in Hirschprung di…
3:31
There are times when it's just not enough to empty that colo…
There are times when it's just not enough to empty that colon. There is discussion of whether or not when you're, when y…
3:53
So in studying the use of Botox in postpo through enterocoli…
So in studying the use of Botox in postpo through enterocolitis, the data is not perfect. According to Doctor Smith, eve…
4:14
Suggest that prophylactic Botox has not been shown to decrea…
Suggest that prophylactic Botox has not been shown to decrease the risk of enterocolitis, but has been shown to decrease…
4:42
And using Botox as part of that treatment strategy would be …
And using Botox as part of that treatment strategy would be beneficial. To sum it up, Hirschsprung disease is characteri…
5:10
The underlying condition of the disease can lead to excessiv…
The underlying condition of the disease can lead to excessive bacterial growth in the colon, emphasizing the need for re…
5:40
Follow our social media channels and download the Stay Curre…
Follow our social media channels and download the Stay Current MD app for tons of content in pediatric surgery. Global C…

Topic Overview

Panel discussion on Botox injection for recurrent Hirschsprung-associated enterocolitis (HAEC) after pull-through surgery. The discussants review a case of a 5-month-old with recurrent HAEC despite normal anatomy, explore the pathophysiology of post-operative enterocolitis (including the role of residual aganglionic internal sphincter and impaired colonic clearance), and examine the evidence for Botox as a treatment strategy. Key clinical points: prophylactic Botox has not been shown to decrease enterocolitis incidence but may reduce hospital length of stay and recurrent admissions in select patients; total colonic Hirschsprung and trisomy 21 are associated with higher HAEC rates; technique varies widely (100 units in 1 mL saline, 3-4 injections at the dentate line is one approach).

Key Takeaways

  • Prophylactic Botox does not reduce enterocolitis incidence but may shorten hospital stays and decrease readmissions. (4:14)
  • Total colonic Hirschsprung and trisomy 21 are associated with significantly higher post-pull-through enterocolitis rates. (3:06)
  • Rectal irrigations alone may be insufficient; residual aganglionic sphincter and poor colonic motility drive HAEC risk. (2:37)
  • Botox technique lacks standardization: reported protocols range widely in dose, volume, and injection sites. (1:33)

Inside this episode

Kai, the Library's AI content creator, listened to this episode and mapped who's speaking, the chapters, key claims, and cases. Every item links to the exact moment in the recording.

AI-enriched

Who's speaking

  • Speaker 1 — host
  • I'm Goddy — host
  • Speaker 3 — guest
  • Doctor Caitlin Smith — guest
  • Speaker 5 — guest
  • Speaker 6 — guest

Chapters

  • 0:00Introduction and Case Presentation — Introduction to the update course rewind series and presentation of a clinical scenario: 5-month-old with Hirschsprung disease, status post Swenson pull-through, now with recurrent HAEC despite normal anatomy on workup.
  • 1:08Botox Technique and Indications — Discussion of the rationale for Botox in post-pull-through patients with recurrent HAEC when mechanical obstruction has been ruled out. Review of Botox injection technique: 100 units in 1 mL saline, 3-4 injections at the dentate line, with or without ultrasound guidance.
  • 2:00Pathophysiology of Post-Operative Enterocolitis — Exploration of why enterocolitis persists after pull-through: residual aganglionic internal sphincter, impaired colonic motility creating bacterial overgrowth, and counterintuitive findings that total colonic Hirschsprung has higher HAEC rates than short-segment disease. Higher rates also seen in trisomy 21.
  • 3:36Evidence for Botox in HAEC — Review of the literature on Botox for post-pull-through enterocolitis. Prophylactic Botox has not been shown to decrease enterocolitis incidence but may reduce hospital length of stay and decrease recurrent admissions in select high-risk patients.
  • 4:47Summary and Conclusion — Recap of key points: Hirschsprung pathophysiology, Botox technique, and evidence suggesting benefit in reducing hospital stays and recurrent episodes rather than preventing initial enterocolitis. Call for further research.

Key claims

  • 1:14Every baby with Hirschsprung disease has a poorly functioning sphincter by nature of the disease — Doctor Caitlin Smith
  • 2:17In order to maintain continence, you want to preserve the dentate line, and you have to leave a tiny bit of aganglionic internal sphincter — Doctor Caitlin Smith
  • 2:23Babies outgrow enterocolitis because their external sphincter is able to overcome their internal sphincter, and that takes time for their body to mature — Doctor Caitlin Smith
  • 2:37The Hirschsprung physiology sets up the colon to act like a pond with poor emptying and motility issues, allowing bacteria to overgrow if the colon is not cleared diligently — Speaker 5
  • 3:06There is a significantly higher rate of enterocolitis in Hirschsprung disease after pull-through when you take out the entire colon compared to babies with shorter segment disease — Doctor Caitlin Smith
  • 3:21There is a much higher rate of enterocolitis in children with trisomy 21 — Doctor Caitlin Smith
  • 3:25You can still get enterocolitis even if you're doing rectal irrigations at home; there are times when it's just not enough to empty that colon — I'm Goddy
  • 3:35There is discussion of whether when you make the diagnosis of total colon Hirschsprung, you should do the colectomy at that time because of the risk of enterocolitis — Doctor Caitlin Smith
  • 3:49There is so much phenotypic variance in Hirschsprung disease that studying the use of Botox in post-pull-through enterocolitis yields imperfect data — Doctor Caitlin Smith
  • 4:14Prophylactic Botox has not been shown to decrease the risk of enterocolitis — Doctor Caitlin Smith
  • 4:14Botox has been shown to decrease the length of stay in patients who have been admitted for enterocolitis — Doctor Caitlin Smith
  • 4:26Botox has been shown to potentially decrease hospitalizations in patients who present with recurrent episodes of obstruction or enterocolitis — Doctor Caitlin Smith
  • 4:34Maybe not everyone needs Botox at the time of pull-through, but there is a subset of patients who have predisposition to enterocolitis for whom Botox as part of treatment strategy would be beneficial — Doctor Caitlin Smith
  • 1:45Botox is often administered as 100 units in 1 mL of saline — Doctor Caitlin Smith
  • 1:48Botox injection technique typically involves 3-4 injections in the dentate line — Doctor Caitlin Smith
  • 1:33People are doing any amount of Botox in any aliquots in any number of locations (technique varies widely in the literature) — Doctor Caitlin Smith

Cases discussed

  • 0:455-month-old male with Hirschsprung disease, status post Swenson pull-through in infancy, now with 2 episodes of HAEC responding to home irrigations

Open questions

  • What is the precise pathophysiology of Hirschsprung-associated enterocolitis after pull-through?
  • Why does total colonic Hirschsprung have a higher rate of enterocolitis than short-segment disease?
  • Why do children with trisomy 21 have higher rates of enterocolitis?
  • Should colectomy be performed at the time of diagnosis in total colonic Hirschsprung to prevent enterocolitis?
  • Which subset of patients would benefit most from Botox as part of their treatment strategy?
  • What is the optimal Botox dosing, injection technique, and timing (prophylactic vs. therapeutic)?
This episode was analyzed and enriched by Kai, the Library's AI content creator. Every item links to the moment it comes from — click a timestamp to listen in context.

Botox for Post-Pull-Through Enterocolitis: When Sphincter Dysfunction Drives Disease

The episode's teaching points arranged as a structured lesson, building from the basics up to the finer points. Written by Kai from the episode transcript and reviewed before publishing.

For trainees · Teaching arc · AI-written, human-reviewed

The Unavoidable Trade-Off in Pull-Through Surgery

Every Hirschsprung pull-through creates a functional problem that sets the stage for enterocolitis 1:14. To preserve continence, the surgeon must leave the dentate line intact and retain a small amount of aganglionic internal sphincter 2:17. This residual aganglionic tissue — the very tissue you operated to bypass — continues to function poorly, creating relative obstruction at the anal canal 1:14. The operation is technically successful, but the physiology remains compromised 1:14. Understanding this trade-off is essential before reaching for Botox: you are not fixing a complication; you are managing an inherent consequence of the disease and its treatment 1:14.

Rule Out the Mechanical Before Treating the Functional

When a child returns with recurrent enterocolitis after pull-through, the first obligation is to exclude mechanical obstruction 2:17. Perform a rectal exam to assess for stricture 2:17. Obtain a contrast enema to evaluate the anastomosis and transition zone 2:17. Review the pathology to confirm no residual aganglionic segment was left behind 2:17. Only after these are cleared can you confidently attribute the enterocolitis to sphincter dysfunction rather than a technical problem 1:14 2:17. Botox injected into a strictured anastomosis or above a retained transition zone will fail, and the child will continue to suffer 1:14 2:17.

The Counterintuitive Epidemiology of HAEC

Total colonic Hirschsprung disease carries a significantly higher rate of post-operative enterocolitis than short-segment disease, despite having less residual colon available for bacterial overgrowth 3:06. This is counterintuitive — you would expect that removing more colon would reduce the bacterial reservoir and lower enterocolitis risk 3:06. The mechanism is not fully understood, but it suggests that enterocolitis is not purely a stasis phenomenon 3:06. Children with trisomy 21 also have a much higher rate of enterocolitis 3:21, pointing to host factors beyond anatomy 3:21. These patterns should lower your threshold for early Botox in high-risk populations 4:34.

The Stagnant Colon as a Bacterial Reservoir

The Hirschsprung colon behaves like a pond: poor motility, inadequate emptying, and a dysfunctional sphincter that resists outflow 2:37. Even with diligent home rectal irrigations, some children cannot clear their colon adequately 3:25. Bacteria overgrow in this stagnant environment, and enterocolitis follows 2:37. Botox addresses one component of this — it reduces sphincter tone and improves emptying 3:25 — but it does not fix motility or immune dysfunction 2:37. Set realistic expectations: Botox is part of a management strategy, not a cure 3:25 4:34.

What the Evidence Shows About Botox

Prophylactic Botox at the time of pull-through has not been shown to decrease the incidence of enterocolitis 4:14. The data do not support routine use in all patients 4:14. However, in children who have already developed enterocolitis, Botox has been shown to decrease length of stay during admissions 4:14 and may reduce the frequency of hospitalizations in those with recurrent obstructive episodes 4:26. The phenotypic variance in Hirschsprung disease makes the evidence imperfect 3:49, but the pattern is consistent: Botox helps the subset of patients whose disease is driven by sphincter dysfunction, not the entire population 3:25 4:34.

Identifying the Right Patient

Not every child with Hirschsprung disease needs Botox, but there is a subset with clear predisposition to enterocolitis for whom Botox should be part of the treatment strategy 4:34. These are the children with total colonic disease 3:06, trisomy 21 3:21, recurrent admissions despite irrigations 3:25 4:26, or documented high sphincter tone on manometry 3:25. For these patients, Botox is not experimental — it is addressing a known pathophysiologic driver 1:14 3:25. The key clinical judgment is recognizing when you have exhausted mechanical explanations and are facing a functional problem that Botox can modify 2:17 3:25 4:34.

The Most Emphasized Point

Before attributing recurrent enterocolitis to sphincter dysfunction and offering Botox, confirm that the pull-through was technically sound 2:17. A poorly functioning sphincter is an expected consequence of Hirschsprung disease 1:14, but a stricture, retained transition zone, or anastomotic problem is a correctable surgical issue 2:17. Botox is the right answer only after the wrong answers have been ruled out 2:17 4:34.

Takeaways from this story

  • Rule out stricture, retained transition zone, and anastomotic problems before attributing recurrent HAEC to sphincter dysfunction.
  • Total colonic Hirschsprung has higher HAEC rates than short-segment disease despite less residual colon—mechanism unclear.
  • Prophylactic Botox does not prevent HAEC, but reduces length of stay and may decrease readmissions in recurrent cases.
  • Target Botox to high-risk patients: total colonic disease, trisomy 21, recurrent admissions despite irrigations.

Keywords

Hashtags

Transcript

Comments

Loading comments…